Other techniques include covalent and allosteric modulation of several molecules involved in Alzheimer’s disease (AD) pathogenesis, such as gamma-secretase and glycogen synthase kinase 3 beta (GSK-3β). The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.